IP Library Granted Patent US 9,089,501
Granted Patent B2
US 9,089,501 · App. 14/137,712 · Granted Jul 28, 2015

Sericin extracted fabrics

Inventors: Gregory H. Altman (Arlington, MA); Rebecca Horan (Arlington, MA); David J. Horan (Westfield, MA); Jingsong Chen (Virginia Beach, VA)
Assignee: Allergan, Inc.
A61K9/70A61K38/17A61L27/227A61L27/3608A61L27/3662A61L27/3804A61L27/386A61L27/3821A61L27/3895A61L27/48C07K14/43518C12N5/066A61F2/00A61F2/08A61K35/12A61L2430/10C12N2533/50Y10T428/298
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,089,501
App. No.
14/137,712
Granted
Jul 28, 2015
Kind
B2
Abstract

Silk is purified to eliminate immunogenic components (particularly sericin) and is used to form fabric that is used to form tissue-supporting prosthetic devices for implantation. The fabrics can carry functional groups, drugs, and other biological reagents. Applications include hernia repair, tissue wall reconstruction, and organ support, such as bladder slings. The silk fibers are arranged in parallel and, optionally, intertwined (e.g., twisted) to form a construct; sericin may be extracted at any point during the formation of the fabric, leaving a construct of silk fibroin fibers having excellent tensile strength and other mechanical properties.

Claims (10)

1. A method for facilitating tissue generation comprising the step of implanting a biodegradable silk fabric into the individual, wherein:

(a) the biodegradable silk fabric is comprised of one or more individual yarns comprised of silkworm derived, sericin-extracted silk fibroin fibers, and;

(b) the silk fibroin fibers have not been dissolved and reconstituted.

2. The method of claim 1 , wherein the fabric is implanted intramuscularly.

3. The method of claim 1 , wherein the fabric is implanted into an individual to replace or repair damaged tissue.

4. The method of claim 1 , wherein the fabric is implanted subcutaneously.

5. The method of claim 1 , wherein the fabric has one or more biomechanical properties of a connective tissue.

6. A method for facilitating tissue generation comprising the step of subcutaneously implanting in an individual a biodegradable silk fabric that has one or more biomechanical properties of a connective tissue into the individual, wherein:

(a) the biodegradable silk fabric is comprised of one or more individual yarns comprised of silkworm derived, sericin extracted silk fibroin fibers, and;

(b) the silk fibroin fibers have not been dissolved and reconstituted, and wherein the fabric is implanted into the individual to replace or repair damaged tissue.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2015
From: ALTMAN, GREGORY H.; HORAN, DAVID; HORAN, REBECCA
To: TISSUE REGENERATION, INC.
Reel/Frame 035250/0921 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2015
From: CHEN, JINGSONG
To: TUFTS UNIVERSITY
Reel/Frame 035251/0027 →
CHANGE OF NAME Recorded Mar 25, 2015
From: TISSUE REGENERATION, INC.
To: SERICA TECHNOLOGIES, INC.
Reel/Frame 035251/0105 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 25, 2015
From: SERICA TECHNOLOGIES, INC.
To: ALLERGAN, INC.
Reel/Frame 035251/0197 →
Continuity (6)
Continuation 13561808 · Jul 30, 2012
Division 12770588 · Apr 29, 2010
Continuation 10800134 · Mar 11, 2004
Continuation In Part 10008924 · Nov 16, 2001
Provisional Application 60453584 · Mar 11, 2003
Related Publication 20140105951A1 · Apr 17, 2014